Phosphoprotein enriched in astrocytes 15 kDa (PEA-15) reprograms growth factor signaling by inhibiting threonine phosphorylation of fibroblast receptor substrate 2α

Molecular Biology of the Cell

Volumn 21, Issue 4, 2010, Pages 664-673

  Haling, Jacob R ^a   Wang, Fen ^b   Ginsberg, Mark H ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST RECEPTOR SUBSTRATE 2 ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; PHOSPHOPROTEIN; PROTEIN PEA 15; THREONINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; ENZYME ACTIVATION; FIBROBLASTS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MAP KINASE SIGNALING SYSTEM; MEMBRANE PROTEINS; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN CONFORMATION; THREONINE;

PISUM SATIVUM;

EID: 76649121518     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E09-08-0659     Document Type: Article

References (51)

1. Araujo, H., Danziger, N., Cordier, J., Glowinski, J., and Chneiweiss, H. (1993). Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J. Biol. Chem. 268, 5911-5920.
2. Bartholomeusz, C., Rosen, D., Wei, C., Kazansky, A., Yamasaki, F., Takahashi, T., Itamochi, H., Kondo, S., Liu, J., and Ueno, N. T. (2008). PEA-15 induces autophagy in human ovarian cancer cells and is associated with prolonged overall survival. Cancer Res. 68, 9302-9310.
3. Bera, T. K., Guzman, R. C., Miyamoto, S., Panda, D. K., Sasaki, M., Hanyu, K., Enami, J., and Nandi, S. (1994). Identification of a mammary transforming gene (MAT1) associated with mouse mammary carcinogenesis. Proc. Natl. Acad. Sci. USA 91, 9789-9793.
4. Cacace, A. M., Michaud, N. R., Therrien, M., Mathes, K., Copeland, T., Rubin, G. M., and Morrison, D. K. (1999). Identification of constitutive and Rasinducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Mol. Cell. Biol. 19, 229-240.
5. Callaway, K., Abramczyk, O., Martin, L., and Dalby, K. N. (2007). The antiapoptotic protein PEA-15 is a tight binding inhibitor of ERK1 and ERK2, which blocks docking interactions at the D-recruitment site. Biochemistry 46, 9187-9198.
6. Chou, F.-L., Hill, J. M., Hsieh, J.-C., Pouyssegur, J., Brunet, A., Glading, A., Uberall, F., Ramos, J. W., Werner, M. H., and Ginsberg, M. H. (2003). PEA-15 binding to ERK1/2 MAPKs is required for its modulation of integrin activation. J. Biol. Chem. 278, 52587-52597.
7. Condorelli, G., Vigliotta, G., Cafieri, A., Trencia, A., Andalo, P., Oriente, F., Miele, C., Caruso, M., Formisano, P., and Beguinot, F. (1999). PED/PEA-15, an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis. Oncogene 18, 4409-4415.
8. Condorelli, G., et al. (1998). PED/PEA-15 gene controls glucose transport and is overexpressed in type 2 diabetes mellitus. EMBO J. 17, 3858-3866.
9. Danziger, N., Yokoyama, M., Jay, T., Cordier, J., Glowinski, J., and Chneiweiss, H. (1995). Cellular expression, developmental regulation, and phylogenic conservation of PEA-15, the astrocytic major phosphoprotein and protein kinase C substrate. J. Neurochem. 64, 1016-1025.
10. Demicheli, R., Abbattista, A., Miceli, R., Valagussa, P., and Bonadonna, G. (1996). Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: further support about the concept of tumor dormancy. Breast Cancer Res. Treat. 41, 177-185.
11. Downward, J. (1996). Control of ras activation. Cancer Surv. 27, 87-100.
12. Embury, J., et al. (2001). Proteins linked to a protein transduction domain efficiently transduce pancreatic islets. Diabetes 50, 1706-1713.
13. Emsley, J. G., Mitchell, B. D., Kempermann, G., and Macklis, J. D. (2005). Adult neurogenesis and repair of the adult CNS with neural progenitors, precursors, and stem cells. Prog. Neurobiol. 75, 321-341.
14. Eulenfeld, R., and Schaper, F. (2009). A new mechanism for the regulation of Gab1 recruitment to the plasma membrane. J. Cell Sci. 122, 55-64.
15. Formstecher, E., et al. (2001). PEA-15 mediates cytoplasmic sequestration of ERK MAP kinase. Dev. Cell 1, 239-250.
16. Gille, H., Strahl, T., and Shaw, P. E. (1995). Activation of ternary complex factor Elk-1 by stress-activated protein kinases. Curr. Biol. 5, 1191-1200.
17. Glading, A., Koziol, J. A., Krueger, J., and Ginsberg, M. H. (2007). PEA-15 inhibits tumor cell invasion by binding to extracellular signal-regulated kinase 1/2. Cancer Res. 67, 1536-1544.
18. Gotoh, N., Laks, S., Nakashima, M., Lax, I., and Schlessinger, J. (2004). FRS2 family docking proteins with overlapping roles in activation of MAP kinase have distinct spatial-temporal patterns of expression of their transcripts. FEBS Lett. 564, 14.
19. Hao, C., Beguinot, F., Condorelli, G., Trencia, A., Van Meir, E. G., Yong, V. W., Parney, I. F., Roa, W. H., and Petruk, K. C. (2001). Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) Mediated apoptosis in human malignant glioma cells. Cancer Res. 61, 1162-1170.
20. Hill, J. M., Vaidyanathan, H., Ramos, J. W., Ginsberg, M. H., and Werner, M. H. (2002). Recognition of ERK MAP kinase by PEA-15 reveals a common docking site within the death domain and death effector domain. EMBO J. 21, 6494-6504.
21. Hughes, P. E., Renshaw, M. W., Pfaff, M., Forsyth, J., Keivens, V. M., Schwartz, M. A., and Ginsberg, M. H. (1997). Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 88, 521-530.
22. Hwang, S., Kuo, W. L., Cochran, J. F., Guzman, R. C., Tsukamoto, T., Bandyopadhyay, G., Myambo, K., and Collins, C. C. (1997). Assignment of HMAT1, the human homolog of the murine mammary transforming gene (MAT1) associated with tumorigenesis, to 1q21.1, a region frequently gained in human breast cancers. Genomics 42, 540-542.
23. Ishibe, S., Joly, D., Zhu, X., and Cantley, L. G. (2003). Phosphorylationdependent paxillin-ERK association mediates hepatocyte growth factor-stimulated epithelial morphogenesis. Mol. Cell 12, 1275-1285.
24. Jacobs, D., Glossip, D., Xing, H., Muslin, A. J., and Kornfeld, K. (1999). Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 13, 163-175.
25. Jensen, C. J., Buch, M.-B., Krag, T. O., Hemmings, B. A., Gammeltoft, S., and Frodin, M. (1999). 90-kDa Ribosomal S6 kinase is phosphorylated and activated by 3-phosphoinositide-dependent protein kinase-1. J. Biol. Chem. 274, 27168-27176.
26. Kitsberg, D., Formstecher, E., Fauquet, M., Kubes, M., Cordier, J., Canton, B., Pan, G., Rolli, M., Glowinski, J., and Chneiweiss, H. (1999). Knock-out of the neural death effector domain protein PEA-15 demonstrates that its expression protects astrocytes from TNFalpha-induced apoptosis. J. Neurosci. 19, 8244-8251.
27. Kouhara, H., Hadari, Y. R., Spivak-Kroizman, T., Schilling, J., Bar-Sagi, D., Lax, I., and Schlessinger, J. (1997). A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway. Cell 89, 693-702.
28. Krueger, J., Chou, F.-L., Glading, A., Schaefer, E., and Ginsberg, M. H. (2005). Phosphorylation of phosphoprotein enriched in astrocytes (PEA-15) regulates extracellular signal-regulated kinase-dependent transcription and cell proliferation. Mol. Biol. Cell 16, 3552-3561.
29. Lax, I., Wong, A., Lamothe, B., Lee, A., Frost, A., Hawes, J., and Schlessinger, J. (2002). The docking protein FRS2alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol. Cell 10, 709-719.
30. Lin, Y., Zhang, J., Zhang, Y., and Wang, F. (2007). Generation of an Frs2alpha conditional null allele. Genesis 45, 554-559.
31. Lovric, J., Dammeier, S., Kieser, A., Mischak, H., and Kolch, W. (1998). Activated Raf induces the hyperphosphorylation of stathmin and the reorganization of the microtubule network. J. Biol. Chem. 273, 22848-22855.
32. Morrison, D. K., and Davis, R. J. (2003). Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19, 91-118.
33. Muller, J., Ory, S., Copeland, T., Piwnica-Worms, H., and Morrison, D. K. (2001). C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol. Cell 8, 983-993.
34. Quilliam, L. A., Zhong, S., Rabun, K. M., Carpenter, J. W., South, T. L., Der, C. J., and Campbell-Burk, S. (1995). Biological and structural characterization of a Ras transforming mutation at the phenylalanine-156 residue, which is conserved in all members of the Ras superfamily. Proc. Natl. Acad. Sci. USA 92, 1272-1276.
35. Ramos, J. W., Hughes, P. E., Renshaw, M. W., Schwartz, M. A., Formstecher, E., Chneiweiss, H., and Ginsberg, M. H. (2000). Death effector domain protein PEA-15 potentiates Ras activation of extracellular signal receptor-activated kinase by an adhesion-independent mechanism. Mol. Biol. Cell 11, 2863-2872.
36. Renault, F., Formstecher, E., Callebaut, I., Junier, M. P., and Chneiweiss, H. (2003). The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes. Biochem. Pharmacol. 66, 1581-1588.
37. Renganathan, H., Vaidyanathan, H., Knapinska, A., and Ramos, J. W. (2005). Phosphorylation of PEA-15 switches its binding specificity from ERK/MAPK to FADD. Biochem. J. 390, 729-735.
38. Sharif, A., Renault, F., Beuvon, F., Castellanos, R., Canton, B., Barbeito, L., Junier, M. P., and Chneiweiss, H. (2004). The expression of PEA-15 (phosphoprotein enriched in astrocytes of 15 kDa) defines subpopulations of astrocytes and neurons throughout the adult mouse brain. Neuroscience 126, 263-275.
39. Shimizu, K., Kaibuchi, K., Nonaka, H., Yamamoto, J., and Takai, Y. (1991). Tissue and subcellular distributions of an inhibitory GDP/GTP exchange protein (GDI) for the rho proteins by use of its specific antibody. Biochem. Biophys. Res. Commun. 175, 199-206.
40. Teis, D., Wunderlich, W., and Huber, L. A. (2002). Localization of the MP1-MAPK scaffold complex to endosomes is mediated by p14 and required for signal transduction. Dev. Cell 3, 803-814.
41. Torii, S., Kusakabe, M., Yamamoto, T., Maekawa, M., and Nishida, E. (2004). Sef is a spatial regulator for Ras/MAP kinase signaling. Dev. Cell 7, 33-44.
42. Tsukamoto, T., et al. (2000). Expression of MAT1/PEA-15 mRNA isoforms during physiological and neoplastic changes in the mouse mammary gland. Cancer Lett. 149, 105-113.
43. Underhill, D. A., Vogan, K. J., Underhill, T. M., and Gros, P. (2001). Identifi-cation of a novel, alternatively spliced isoform and single nucleotide polymorphisms in the murine Pea-15 gene. Mamm. Genome 12, 172-174.
44. Vaidyanathan, H., Opoku-Ansah, J., Pastorino, S., Renganathan, H., Matter, M. L., and Ramos, J. W. (2007). ERK MAP kinase is targeted to RSK2 by the phosphoprotein PEA-15. Proc. Natl. Acad. Sci. USA 104, 19837-19842.
45. Vaidyanathan, H., and Ramos, J. W. (2003). RSK2 activity is regulated by its interaction with PEA-15. J. Biol. Chem. 278, 32367-32372.
46. Viparelli, F., et al. (2008). Targeting of PED/PEA-15 molecular interaction with phospholipase D1 enhances insulin sensitivity in skeletal muscle cells. J. Biol. Chem. 283, 21769-21778.
47. Whitehurst, A. W., Robinson, F. L., Moore, M. S., and Cobb, M. H. (2004). The death effector domain protein PEA-15 prevents nuclear entry of ERK2 by inhibiting required interactions. J. Biol. Chem. 279, 12840-12847.
48. Wu, Y., Chen, Z., and Ullrich, A. (2003). EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2. Biol. Chem. 384, 1215-1226.
49. Xiao, C., Yang, B. F., Asadi, N., Beguinot, F., and Hao, C. (2002). Tumor necrosis factor-related apoptosis-inducing ligand-induced death-inducing signaling complex and its modulation by c-FLIP and PED/PEA-15 in glioma cells. J. Biol. Chem. 277, 25020-25025.
50. Zhang, Y., Redina, O., Altshuller, Y. M., Yamazaki, M., Ramos, J., Chneiweiss, H., Kanaho, Y., and Frohman, M. A. (2000). Regulation of expression of phospholipase D1 and D2 by PEA-15, a novel protein that interacts with them. J. Biol. Chem. 275, 35224-35232.
51. Zhou, M., Horita, D. A., Waugh, D. S., Byrd, R. A., and Morrison, D. K. (2002). Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR). J. Mol. Biol. 315, 435-446.